Clenbuterol Hydrochloride

盐酸克仑特罗

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameClenbuterol Hydrochloride
Drug Alias Name瘦肉精clenbuterol盐酸克伦特罗clenbuterolum氨双氯喘 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsCognitive DysfunctionEmphysemaDiabetes Mellitus, Type 2 +[10] 
Global Approved IndicationsEmphysemaRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive +[5] 
Approved Indications in ChinaEmphysemaPulmonary Disease, Chronic ObstructiveAsthma +[4] 
Original Approved Country/TerritoryGermany
Original Approved Date1976/12/12
Country/TerritoryUnited StatesNetherlandsItaly +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMaastricht UniversityUniversity Of RochesterUniversity Of Washington +[6] 
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionEmphysemaDiabetes Mellitus, Type 2 +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeR03AC14R03CC13
Related LinksWikipediaDrugBankKEGG